Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
OA02 - A New Vision of Targets and Strategies
- 10:30 - 12:00
- 9/08/2019
- Location: Seoul (2007)
- IASLC CME Accredited
- Type: Oral Session
- Track: Targeted Therapy
- Moderators:Frank Griesinger, Luis Paz-Ares
-
+
OA02.01 - Alectinib in Previously Treated RET-Rearranged Advanced Non-Small-Cell Lung Cancer: A Phase 1/2 Trial (ALL-RET)
10:30 - 10:40 | Presenter: Noriko Yanagitani | Author(s): Shinji Takeuchi, Toshinori Murayama, Kenichi Yoshimura, Yasuhito Imai, Shizuko Takahara, Takahiro Kawakami, Takashi Seto, Yoshihiro Hattori, Kadoaki Ohashi, Masahiro Morise, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto, Makoto Nishio, Seiji Yano
- Abstract
Loading... -
+
OA02.02 - Phase 1 Study of Safety, Tolerability, PK and Efficacy of AMG 510, a Novel KRAS G12C Inhibitor, Evaluated in NSCLC
10:40 - 10:50 | Presenter: Ramaswamy Govindan | Author(s): Marwan G Fakih, Timothy J Price, Gerald S Falchook, Jayesh Desai, James C Kuo, John H Strickler, John C Krauss, Bob T Li, Crystal S Denlinger, Greg Durm, Jude Ngang, Haby Henary, Gataree Ngarmchamnanrith, Erik Rasmussen, Phuong Khanh Morrow, David S. Hong
- Abstract
Loading... -
+
OA02.03 - The Third Generation EGFR Inhibitor (EGFR-TKI) HS-10296 in Advanced NSCLC Patients with Resistance to First Generation EGFR-TKI
10:50 - 11:00 | Presenter: Shun Lu | Author(s): Qiming Wang, Guojun Zhang, Xiaorong Dong, Cheng-Ta Yang, Yong Song, Gee-Chen Chang, You Lu, Hongming Pan, Chao-Hua Chiu, Zhehai Wang, Jifeng Feng, Jianying Zhou, Xingxiang Xu, Renhua Guo, Jianhua Chen, Haihua Yang, Yuan Chen, Zhuang Yu, Her-Shyong Shiah, Chin-Chou Wang, Nong Yang, Jian Fang, Ping Wang, Kai Wang, Yanping Hu, Jianxing He, Ziping Wang, Jianhua Shi, Shaoshui Chen, Ying Cheng, Wu-Chou Su, Te-Chun Hsia, Jiuwei Cui, yuping Sun, Chih-Hsin Yang
- Abstract
Loading... -
+
OA02.04 - Discussant - OA02.01, OA02.02, OA02.03
11:00 - 11:15 | Presenter: Jon Zugazagoitia
- Abstract
No abstract available for this presentation
-
+
OA02.05 - First-In-Human Phase 1/2 Trial of Anti-AXL Antibody–Drug Conjugate (ADC) Enapotamab Vedotin (EnaV) in Advanced NSCLC
11:15 - 11:25 | Presenter: Suresh S Ramalingam | Author(s): Juanita Lopez, Morten Mau-Sorensen, Fiona Thistlethwaite, Sarina Piha-Paul, Shirish Gadgeel, Yvette Drew, Pasi A Jänne, Aaron S. Mansfield, Guang Chen, Ulf Forssmann, Hrefna Kristin Johannsdottir, Nora Pencheva, Annette Ervin-Haynes, Ignace Vergote
- Abstract
Loading... -
+
OA02.06 - The Sequential Therapy of Crizotinib Followed by Alectinib: Real World Data of 840 Patients with NSCLC Harboring ALK-Rearrangement (WJOG9516L)
11:25 - 11:35 | Presenter: Satomi Watanabe | Author(s): Takeharu Yamanaka, Kentaro Ito, Shinya Sakata, Haruko Daga, Takashi Kijima, Katsuya Hirano, Isamu Okamoto, Atsushi Nakamura, TOSHIYUKI Kozuki, Mikiko Ishihara, Koichi Azuma, Takashi Seto, Toshihide Yokoyama, Yuko Oya, Haruki Kobayashi, Kazumi Nishino, Yoshihiro Hattori, Kazuhiko Nakagawa, Nobuyuki Yamamoto
- Abstract
Loading... -
+
OA02.07 - Phase 3 ALUR Study of Alectinib in Pretreated ALK+ NSCLC: Final Efficacy, Safety and Targeted Genomic Sequencing Analyses
11:35 - 11:45 | Presenter: Juergen Wolf | Author(s): Åslaug Helland, In-Jae Oh, Maria Rita Migliorino, Rafal Dziadziuszko, Javier De Castro Carpeno, Julien Mazieres, Frank Griesinger, Marijana Chlistalla, Andres Cardona, Thorsten Ruf, Kerstin Trunzer, Vlatka Smoljanovic, Silvia Novello
- Abstract
Loading... -
+
OA02.08 - Discussant - OA02.05, OA02.06, OA02.07
11:45 - 12:00 | Presenter: Michael Duruisseaux
- Abstract
No abstract available for this presentation
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-26 - TP53 Mutations in EGFR mt+ NSCLC IV: Strong Independent Predictive Factor for ORR, PFS and OS Irrespective of T790M
09:45 - 09:45 | Presenter: Julia Roeper | Author(s): Markus Falk, Fabian Otto-Sobotka, Frank Griesinger
- Abstract
Loading...
-
+
MA11 - Immunotherapy in Special Populations and Predictive Markers
- 14:00 - 15:30
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Immuno-oncology
- Moderators:Frank Griesinger, Lecia Sequist
-
+
MA11.01 - Multifactorial Model to Predict Response to PD-(L)1 Blockade in Patients with High PD-L1 Metastatic Non-Small Cell Lung Cancer
14:00 - 14:05 | Presenter: Kathryn C. Arbour | Author(s): Miruna Oprescu, Joe Hakim, Hira Rizvi, Mark Leiserson, Michelle Ginsburg, Andrew J. Plodkowski, Jennifer Sauter, Isabel Preeshagul, Sharon Gillett, Philip Rosenfield, Lester Mackey, Miroslav Dudik, Matthew Hellmann
- Abstract
Loading... -
+
MA11.02 - KEYNOTE-042 China Study: First-Line Pembrolizumab vs Chemotherapy in Chinese Patients with Advanced NSCLC with PD-L1 TPS ≥1%
14:05 - 14:10 | Presenter: Yi-Long Wu | Author(s): Li Zhang, Yun Fan, Jianying Zhou, Li Zhang, Qing Zhou, Wei Li, ChengPing Hu, Gongyan Chen, Xin Zhang, Caicun Zhou, Thao Dang, Justina Penrod, Debra A. Kush, Yun Qin, Ben Li, Tony Mok
- Abstract
Loading... -
+
MA11.03 - Pembrolizumab Plus Docetaxel Increases Progression-Free Survival Compared with Docetaxel Alone in Previously Treated Advanced Non-Small Cell Lung Cancer Patients
14:10 - 14:15 | Presenter: Oscar Gerardo Arrieta | Author(s): Feliciano Barrón, Amir Carmona, Laura Alejandra Ramírez-Tirado, Zyanya Lucia Zatarain Barrón, Andrés Felipe Cardona, Yolanda Bautista, Fernando Aldaco, Miguel Lazaro, Renata Baez, Raquel Gerson, Carolina Blanco
- Abstract
Loading... -
+
MA11.04 - Platinum Doublet + Durvalumab +/- Tremelimumab in Patients with Advanced NSCLC: A CCTG Phase IB Study - IND.226
14:15 - 14:20 | Presenter: Rosalyn Anne Juergens | Author(s): Peter M Ellis, Dongsheng Tu, Desiree Hao, Scott A Laurie, Mihaela Mates, Glenwood D. Goss, John Goffin, Penelope A Bradbury, Mustapha Tehfe, Christian Kollmansberger, Pamela Brown-Walker, Martin Smoragiewicz, Ming Sound Tsao, Lesley Seymour
- Abstract
Loading... -
+
MA11.05 - Discussant - MA11.01, MA11.02, MA11.03, MA11.04
14:20 - 14:35 | Presenter: Lizza Hendriks
- Abstract
No abstract available for this presentation
-
+
MA11.06 - A PII Study of Toripalimab, a PD-1 mAb, in Combination with Chemotherapy in EGFR+ Advanced NSCLC Patients Failed to Prior EGFR TKI Therapies
14:35 - 14:40 | Presenter: Jie Zhang | Author(s): Caicun Zhou, yanqiu Zhao, Xiaoqian Mu, Jianying Zhou, Zhang Bao, Yun Fan, Yanjun Xu, Yongqian Yong Shu, Renhua Guo, Xiaoqing Liu, Hong Wang, Helong Zhang, Lin Deng, Ningqiang Ma, Jianxing He, Yalei Zhang, mo Chen, Yinrui Jiang
- Abstract
Loading... -
+
MA11.07 - Efficacy of Immune-Checkpoint Inhibitors and EGFR-TKIs in NSCLC Patients with High PD-L1 Expression
14:40 - 14:45 | Presenter: Ken Masuda | Author(s): Hidehito Horinouchi, Midori Tanaka, Ryoko Higashiyama, Yuki Shinno, Jun Sato, Tatsuya Yoshida, Yuji Matsumoto, Yasushi Goto, Shintaro Kanda, Noboru Yamamoto, Yuichiro Ohe
- Abstract
Loading... -
+
MA11.08 - Discussant - MA11.06, MA11.07
14:45 - 15:00 | Presenter: Qing Zhou
- Abstract
No abstract available for this presentation
-
+
MA11.09 - Increased Frequency of Bystander T Cells in the Lungs Is Associated with Recurrence in Localized Non-Small Cell Lung Cancer
15:00 - 15:05 | Presenter: Alexandre Reuben | Author(s): Jiexin Zhang, Rachel Gittelman, Shin-Heng Chiou, Jun Li, Junya Fujimoto, Carmen Behrens, Farrah Kheradmand, Chi-Wan Chow, Chantale Bernatchez, Agda Karina Eterovic, Sharon Benzeno, Marissa Vignali, Xifeng Xifeng Wu, Yuanqing Ye, Tina Cascone, Roy S. Herbst, Stephen Swisher, Humam Kadara, Cesar Moran, Jianhua Zhang, Paul Scheet, Ara A Vaporciyan, Boris Sepesi, Don Lynn Gibbons, Harlan Robins, Patrick Hwu, John Victor Heymach, Padmanee Sharma, James Allison, Jack Lee, Mark Davis, Ignacio Wistuba, P. Andrew Futreal, Jianjun Zhang
- Abstract
Loading... -
+
MA11.10 - Peripheral T Cell Repertoire Evolution in Resectable NSCLC Treated with Neoadjuvant PD-1 Blockade
15:05 - 15:10 | Presenter: Justina X Caushi | Author(s): Jiajia Zhang, Zhicheng Ji, Marguerrita El Asmar, Valsamo Anagnostou, Tricia R Cottrell, Hok Yee Chan, Haidan Guo, Taha Merghoub, Jamie E. Chaft, Jedd D Wolchok, Joshua Reuss, Kristen A Marrone, Jarushka Naidoo, Edward Gabrielson, Janis M Taube, Julie R Brahmer, Victor Velculescu, Ni Zhao, Matthew Hellmann, Patrick M. Forde, Drew M Pardoll, Srinivasan Yegnasubramanian, Hongkai Ji, Kellie Smith
- Abstract
Loading... -
+
MA11.11 - STK11/LKB1 Genomic Alterations Are Associated with Inferior Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC
15:10 - 15:15 | Presenter: John Victor Heymach | Author(s): Ferdinandos Skoulidis, Kathryn C. Arbour, Matthew Hellmann, Pradnya Dinkar Patil, Melina E Marmarelis, Dwight Hall Owen, Mark Awad, Joseph C. Murray, Benjamin Philip Levy, Jessica Hellyer, Justin F. Gainor, Tyler Stewart, Sarah B. Goldberg, Anastasios Dimou, Christine M Bestvina, Amy Lauren Cummings, Yasir Elamin, Vincent Lam, Jianjun Zhang, Catherine Shu, Jonathan Wesley Riess, Collin M Blakely, Chad V. Pecot, Laura Mezquita, Fabrizio Tabbò, Adrian G Sacher, Matthias Scheffler, Biagio Ricciuti, Deepti Venkatraman, Hira Rizvi, Corinne Liu, Rocio Perez Johnston, Ying Ni, Joseph Azok, Melanie Wain Kier, Sharyn I Katz, Kurtis D. Davies, Jeremy P Segal, Lauren Ritterhouse, Hiram Shaish, LUDOVIC Lacroix, Regan Memmott, John R Madrigal, Jonathan Goldman, Sally CM Lau, Jonathan Killam, Zenta Walther, Brett Carter, Mark Woodcock, Jack Roth, Stephen Swisher, Natasha B Leighl, Subba Digumarthy, Meghan Mooradian, Julia Rotow, Juergen Wolf, Giorgio Vittorio Scagliotti, David Planchard, Benjamin Besse, Trever G Bivona, David R Gandara, Edward Garon, Naiyer A Rizvi, D. Ross Camidge, Kurt A Schalper, Roy S. Herbst, Alice T. Shaw, Joel W Neal, Heather A Wakelee, Julie R Brahmer, Pasi A Jänne, David P Carbone, Charu Aggarwal, Nathan Pennell, Charles M Rudin, Vassiliki A Papadimitrakopoulou
- Abstract
Loading... -
+
MA11.12 - Discussant - MA11.09, MA11.10, MA11.11
15:15 - 15:30 | Presenter: Ana Zimmer Gelatti Gelatti
- Abstract
No abstract available for this presentation
-
+
P2.04 - Immuno-oncology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P2.04-63 - Evaluation of Combined Biomarkers for Tumor Response to Immunotherapy (I/O) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10:15 - 10:15 | Presenter: Hayat Oum El Kheir Ramdani | Author(s): Markus Falk, Stefanie Schatz, Markus Tiemann, Lukas C Heukamp, Ed Schuuring, Harry JM Groen, Frank Griesinger
- Abstract
Loading...
-
+
OA15 - Targeted Agents and Immunotherapy for Small Cell Lung Cancer
- 14:30 - 16:00
- 9/10/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Oral Session
- Track: Small Cell Lung Cancer/NET
- Moderators:Raffaele Califano, Charles M Rudin
-
+
OA15.05 - BIOLUMA: A Phase II Trial of Nivolumab and Ipilimumab in Lung Cancer – Prospective Evaluation of TMB in SCLC Patients
15:15 - 15:25 | Presenter: Julie George | Author(s): Rieke Nila Fischer, Andreas H Scheel, Hans Schlösser, Maria Vehreschild, Diana S.Y. Abdulla, Sophia Koleczko, Sebastian Michels, Lucia Nogova, Richard Riedel, Matthias Scheffler, Lukas Maas, Peter Brossart, Walburga Engel-Riedel, Frank Griesinger, Christian Grohé, Jens Kern, Barbara Hermes, Kathrin Nachtkamp, Jens Peter Panse, Martin Sebastian, Markus Lehmann, Rainer Gerhard Wiewrodt, Reinhard Buettner, Roman Thomas, Juergen Wolf
- Abstract
As requested by the author, the abstract for this presentation will not be published